ClinicalTrials.gov
ClinicalTrials.gov Menu

SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00299832
Recruitment Status : Completed
First Posted : March 7, 2006
Last Update Posted : November 18, 2016
Sponsor:
Information provided by (Responsible Party):
Novartis

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2007
  Actual Study Completion Date : May 2007